Ignatia amara (Schwabe North America, Inc.)
Welcome to the PulseAid listing for the Ignatia amara drug offered from Schwabe North America, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Schwabe North America, Inc. |
| NON-PROPRIETARY NAME: | Ignatia amara |
| SUBSTANCE NAME: | STRYCHNOS IGNATII SEED |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2006-01-01 |
| END MARKETING DATE: | 2019-02-28 |
Ignatia amara HUMAN OTC DRUG Details:
| Item Description | Ignatia amara from Schwabe North America, Inc. |
| LABELER NAME: | Schwabe North America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30([hp_X]/1) |
| START MARKETING DATE: | 2006-01-01 |
| END MARKETING DATE: | 2019-02-28 |
| PRODUCT ID: | 53499-6372_eae941e0-e1e7-4fdd-8158-6a828f0416f5 |
| PRODUCT NDC: | 53499-6372 |
| APPLICATION NUMBER: | |
Other STRYCHNOS IGNATII SEED Pharmaceutical Manufacturers / Labelers:
